Pharma giant Cipla on Thursday reported 4% year-on-year (year-on-year) growth in its consolidated net profit at Rs 1,351 crore, while revenue from operations rose 8% year-on-year to Rs 7,589 crore. Second quarter EBITDA improved by a marginal 0.5% year-on-year to Rs 1,895 crore. The margins were 25%. Segment-wise, the Indian business generated Rs 3,146 crore, […]
Cipla shares rose by 6% during the last two trading sessions to touch a highlight of RS 1,575 on the BSE on Monday, powered by strong Q1FY26 income and a wave of bullish comments from brokerage houses. After the results, various brokerage companies have revised their target price for the share, with estimates that are […]